HLS Therapeutics, Inc. (HLS.TO)
3.72
-0.12
(-3.12%)
CAD |
TSX |
Aug 26, 11:39
HLS Therapeutics Total Assets (Quarterly) : 182.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 182.38M |
| March 31, 2026 | 182.94M |
| December 31, 2025 | 188.52M |
| September 30, 2025 | 195.11M |
| June 30, 2025 | 203.41M |
| March 31, 2025 | 221.57M |
| December 31, 2024 | 229.97M |
| September 30, 2024 | 232.01M |
| June 30, 2024 | 261.80M |
| March 31, 2024 | 267.61M |
| December 31, 2023 | 275.67M |
| September 30, 2023 | 290.99M |
| June 30, 2023 | 300.14M |
| March 31, 2023 | 316.89M |
| December 31, 2022 | 327.43M |
| September 30, 2022 | 343.97M |
| June 30, 2022 | 343.94M |
| March 31, 2022 | 337.90M |
| December 31, 2021 | 348.51M |
| September 30, 2021 | 359.68M |
| June 30, 2021 | 366.67M |
| March 31, 2021 | 372.95M |
| December 31, 2020 | 387.18M |
| September 30, 2020 | 408.73M |
| June 30, 2020 | 397.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 436.13M |
| December 31, 2019 | 414.53M |
| September 30, 2019 | 428.13M |
| June 30, 2019 | 437.39M |
| March 31, 2019 | 400.54M |
| December 31, 2018 | 418.52M |
| September 30, 2018 | 417.25M |
| June 30, 2018 | 484.16M |
| March 31, 2018 | 497.45M |
| December 31, 2017 | |
| September 30, 2017 | 33.43M |
| June 30, 2017 | 33.61M |
| March 31, 2017 | 33.87M |
| December 31, 2016 | 34.31M |
| September 30, 2016 | 34.72M |
| June 30, 2016 | 34.93M |
| March 31, 2016 | 35.34M |
| December 31, 2015 | 36.91M |
| September 30, 2015 | 37.65M |
| June 30, 2015 | 53.43M |
| March 31, 2015 | 57.40M |
| December 31, 2014 | 69.85M |
| September 30, 2014 | 69.37M |
| June 30, 2014 | 64.60M |
| March 31, 2014 | 59.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | 35.18B |
| Cipher Pharmaceuticals, Inc. | 222.59M |
| BioSyent, Inc. | 60.46M |
| Revive Therapeutics Ltd. | 0.2818M |
| Knight Therapeutics, Inc. | 1.045B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.01M |
| Shareholders Equity (Quarterly) | 78.37M |
| Debt to Equity Ratio | 0.7586 |
| Current Ratio | 1.049 |
| Net Debt Paydown Yield | 4.68% |